Cargando…
Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy
Background: Diabetic retinopathy (DR) is a common complication of type 2 diabetes mellitus (T2DM) and the leading cause of blindness in adults. DR pathogenesis has not been fully elucidated, but inflammation is widely accepted to play an important role. Emerging evidence suggests that the platelet-t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555325/ https://www.ncbi.nlm.nih.gov/pubmed/26308022 http://dx.doi.org/10.3390/ijerph120810009 |
_version_ | 1782388180500086784 |
---|---|
author | Yue, Song Zhang, Jiahua Wu, Jingyang Teng, Weiping Liu, Lei Chen, Lei |
author_facet | Yue, Song Zhang, Jiahua Wu, Jingyang Teng, Weiping Liu, Lei Chen, Lei |
author_sort | Yue, Song |
collection | PubMed |
description | Background: Diabetic retinopathy (DR) is a common complication of type 2 diabetes mellitus (T2DM) and the leading cause of blindness in adults. DR pathogenesis has not been fully elucidated, but inflammation is widely accepted to play an important role. Emerging evidence suggests that the platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and neutrophil-to-lymphocyte ratio (NLR) are novel potential markers of inflammatory responses. The present study aimed to evaluate the associations between DR and the PLR, MLR, and NLR. Patients and Methods: We performed a case-control study involving 247 patients with T2DM. The patients were divided into three groups: 125 control subjects with T2DM, 63 diabetic subjects with non-proliferative diabetic retinopathy (NPDR), and 59 patients with proliferative diabetic retinopathy (PDR). Results: The mean PLR and NLR were significantly higher in patients with DR compared with patients without DR (p < 0.01, p = 0.02, respectively). The mean MLR in the NPDR group was higher than that of patients without DR, but there were no significant differences among the three groups (p = 0.07). Logistic regression showed that the MLR was an independent risk factor for DR (odds ratio [OR]: 54.574, 95% confidence interval [CI]: 2.708–1099.907). Based on the receiver operating characteristic (ROC) curve, use of the MLR as an indicator for DR diagnosis was projected to be 2.25, and yielded a sensitivity and specificity of 47.1% and 69.6%, respectively, with an area under the curve of 0.581 (95% CI: 0.510–0.653). Conclusions: The PLR and NLR are significantly increased in the setting of DR. After correcting for possible confounding factors, the MLR was found to be a risk factor for DR. Although the MLR may be pathophysiologically and clinically relevant in DR, its predictive ability was limited. |
format | Online Article Text |
id | pubmed-4555325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-45553252015-09-01 Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy Yue, Song Zhang, Jiahua Wu, Jingyang Teng, Weiping Liu, Lei Chen, Lei Int J Environ Res Public Health Article Background: Diabetic retinopathy (DR) is a common complication of type 2 diabetes mellitus (T2DM) and the leading cause of blindness in adults. DR pathogenesis has not been fully elucidated, but inflammation is widely accepted to play an important role. Emerging evidence suggests that the platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and neutrophil-to-lymphocyte ratio (NLR) are novel potential markers of inflammatory responses. The present study aimed to evaluate the associations between DR and the PLR, MLR, and NLR. Patients and Methods: We performed a case-control study involving 247 patients with T2DM. The patients were divided into three groups: 125 control subjects with T2DM, 63 diabetic subjects with non-proliferative diabetic retinopathy (NPDR), and 59 patients with proliferative diabetic retinopathy (PDR). Results: The mean PLR and NLR were significantly higher in patients with DR compared with patients without DR (p < 0.01, p = 0.02, respectively). The mean MLR in the NPDR group was higher than that of patients without DR, but there were no significant differences among the three groups (p = 0.07). Logistic regression showed that the MLR was an independent risk factor for DR (odds ratio [OR]: 54.574, 95% confidence interval [CI]: 2.708–1099.907). Based on the receiver operating characteristic (ROC) curve, use of the MLR as an indicator for DR diagnosis was projected to be 2.25, and yielded a sensitivity and specificity of 47.1% and 69.6%, respectively, with an area under the curve of 0.581 (95% CI: 0.510–0.653). Conclusions: The PLR and NLR are significantly increased in the setting of DR. After correcting for possible confounding factors, the MLR was found to be a risk factor for DR. Although the MLR may be pathophysiologically and clinically relevant in DR, its predictive ability was limited. MDPI 2015-08-21 2015-08 /pmc/articles/PMC4555325/ /pubmed/26308022 http://dx.doi.org/10.3390/ijerph120810009 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yue, Song Zhang, Jiahua Wu, Jingyang Teng, Weiping Liu, Lei Chen, Lei Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title_full | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title_fullStr | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title_full_unstemmed | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title_short | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy |
title_sort | use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555325/ https://www.ncbi.nlm.nih.gov/pubmed/26308022 http://dx.doi.org/10.3390/ijerph120810009 |
work_keys_str_mv | AT yuesong useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy AT zhangjiahua useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy AT wujingyang useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy AT tengweiping useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy AT liulei useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy AT chenlei useofthemonocytetolymphocyteratiotopredictdiabeticretinopathy |